Home

Vivo Ventures Fund VI, L.P.

CIK 1469473 · last filed 2015-11-04

Vivo Ventures Fund VI, L.P. is a corporate insider who has filed 3 SEC Form 4 insider transactions across 2 companies since 2009. The most recent filing shows the insider sold $32.9M of SGNT on Nov 4, 2015. Across all open-market trades the lifetime net is −$34.8M, making them a net seller over the disclosed history. The firm reports its address in Palo Alto, CA. 13 SEC filings were submitted jointly with Vivo Ventures VI, LLC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

3

Lifetime Open-Market Net

-$34.84M

Filer Profile

Reported Address
575 HIGH STREET, SUITE 201
PALO ALTO, CA 94301
Phone
(650) 688-0818
State of Incorporation
DE
Related Filers
Vivo Ventures VI, LLC — 13 joint filings, latest 2016-09-01
VIVO VENTURES VI AFFIILATES FUND, L.P. — 10 joint filings, latest 2016-09-01
Vivo Ventures V Affiliates Fund, L.P. — same reported address
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Sagent Pharmaceuticals, Inc. (SGNT) Delisted 10%+ Owner 3,458,631 — — -$32.87M 1 2015-11-04
AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted 10%+ Owner 8,282,003 — — -$1.97M 1 2009-08-13

Recent Filings

3 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2015-11-04 Sagent Pharmaceuticals, Inc. (SGNT) Delisted Sell (S) −2,090,469 -$32.87M EDGAR
2015-04-14 — Mixed +12,613,692 $15.19M
2009-08-13 AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted Sell (S) −564,500 -$1.97M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.